Rivoluzionare lo screening del cancro colorettale e delle emorragie intestinali con il test fecale della transferrina
As we celebrate 12.12 (Global Universal Health Coverage Day), a day dedicated to promoting equitable access to healthcare for all, we are proud to introduce our Transferrin Fecal Test, an innovative, rapid, and affordable tool for the early detection of intestinal bleeding and colorectal cancer. This test is a vital step toward achieving better health outcomes through early diagnosis and improved screening access for everyone, everywhere.
What is the Transferrin Fecal Test?
The Transferrin Test is a non-invasive diagnostic tool that detects elevated levels of transferrin in stool samples, a key indicator of intestinal bleeding. Intestinal bleeding is a common symptom of conditions such as colorectal cancer, which often develops without symptoms in the early stages. By detecting transferrin in feces, this test helps identify potential cases of gastrointestinal bleeding, enabling early diagnosis and intervention.
Aligning with Universal Health Coverage Goals
The Transferrin Fecal Test Kit supports Universal Health Coverage (UHC) by providing affordable and accessible screening for colorectal cancer and gastrointestinal disorders, ensuring everyone has access to early diagnosis, regardless of location or financial status.
· Empowering Early Diagnosis:
Early detection through our rapid and cost-effective test helps reduce the risk of advanced colorectal cancer, improving survival rates and bringing us closer to universal access to healthcare.
· Expanding Access to Screening:
Our test is easy to use and affordable, promoting widespread screening, especially in underserved areas. It can be used in mobile clinics, rural health centers, and home testing programs, ensuring no one is left behind in the fight against colorectal cancer.
